Literature DB >> 23271443

Paradoxical reaction during tuberculosis treatment in immunocompetent children: clinical spectrum and risk factors.

Carole Olive1, Françoise Mouchet, Véronique Toppet, Edwige Haelterman, Jack Levy.   

Abstract

BACKGROUND: Paradoxical reaction (PR) during antituberculosis (TB) therapy, defined as clinical or radiologic worsening of preexisting TB lesions or the development of new lesions, has not been widely studied in immunocompetent children.
METHODS: All children (<17 years) with the diagnosis of TB who sought care at our center between 1994 and 2007 were included in this retrospective study. Data on demographic characteristics, bacteriologic results, medical imaging, treatment regimens and outcomes were abstracted from medical records. Patients with and without PR were compared.
RESULTS: Of 115 TB cases, 12 (10.3%) developed PR. Children with PR were younger than those with TB without complication: median age at diagnosis was 26 months (range, 5-148) compared with 66 months (range, 6-205) for those without complications (P = 0.013). None of the children in the PR group had received Calmette-Guérin bacillus vaccination, compared with 34 of 103 (33%) children without PR (P = 0.017). Children with a diagnosis of PR were more frequently symptomatic at diagnosis of TB disease when compared with children without PR (P = 0.028). PR occurred at a median interval of 39 days (range, 15-75) after initiation of antituberculosis treatment. The most common PR was worsening of preexisting pulmonary lesions (75%). New lesions in anatomical sites other than those observed at initial presentation developed in 3 children.
CONCLUSION: Paradoxical deterioration during treatment of TB disease is common in immunocompetent children. Young age and absence of Calmette-Guérin bacillus vaccination appeared to be associated with PR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23271443     DOI: 10.1097/INF.0b013e3182846c4e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Encounters with an old foe: Childhood tuberculosis in Canada.

Authors:  Ian Kitai; Shaun K Morris
Journal:  Paediatr Child Health       Date:  2014-02       Impact factor: 2.253

2.  Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.

Authors:  D A Barr; A K Coussens; S Irvine; N D Ritchie; K Herbert; B Choo-Kang; D Raeside; D J Bell; R A Seaton
Journal:  Int J Tuberc Lung Dis       Date:  2017-06-01       Impact factor: 2.373

3.  Tuberculosis-immune reconstitution inflammatory syndrome in HIV-negative children.

Authors:  Apinya Palamit; Prakarn Tovichien; Ramida Amornsitthiwat
Journal:  Respirol Case Rep       Date:  2022-03-30

4.  Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: A case report.

Authors:  Ping Liu; Ning Pei; Xuhui Liu; Wei Huang; Shuihua Lu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.